Additional fatalities reported from COVID-19 and pneumonia, with five individuals succumbing to these diseases
In the last 24 hours, 179 fresh cases of pneumonia resembling COVID-19 symptoms have surfaced in Almaty, Kazakhstan, according to Almaty.tv, citing the Ministry of Health.
The grim news is that two individuals have succumbed to the virus, while 73 fortunate patients have regained their health.
Since August 1, a total of 32,979 cases have been reported, claiming the lives of 355 people, but thankfully, 27,242 have had a successful recovery.
An additional 61 cases have been diagnosed as COVID-19, resulting in three deaths among Kazakhstan residents. Currently, 3,308 patients are undergoing treatment, with 59 of them being children. At present, 1,813 individuals are hospitalized, while 1,495 are receiving care at home. The critical condition of 94 patients is a cause for concern, as are the 13 in severe condition, and the 21 dependent on ventilators.
Initially, it was reported that 63 people had recovered from COVID-19 over the past 24 hours.
As for the current situation, recent studies and reports lack specific data regarding the COVID-19 scenario in Almaty. However, research conducted in 2025 provides some insights into vaccine acceptance, immunization coverage, and barriers to COVID-19 vaccine uptake in Kazakhstan, shedding light on broader COVID-19 control efforts [1].
A study from Almaty also indicates a shift from asymptomatic screenings to symptomatic presentations, potentially affecting case detection dynamics or healthcare-seeking behavior. Furthermore, drops in certain healthcare metrics suggest the pandemic's impact on COVID-19 and other disease management [2].
Mental health trends have also worsened due to social isolation and the digitalization effects of the pandemic in the post-COVID context, further complicating already strained healthcare systems [4].
Sadly, the sources at hand do not provide explicit current numbers such as confirmed COVID-19 cases, deaths, recoveries, or detailed hospitalization data for Almaty as of May 2025. To obtain the most accurate and updated statistics, it's advisable to check official Kazakhstan health ministry releases or local Almaty health department reports.
In summary, while the precise COVID-19 figures for Almaty are unavailable from the provided data, ongoing research highlights vaccine coverage challenges, shifts in disease presentation, and broader health impacts in Kazakhstan related to COVID-19 as of mid-2025 [1][2][4].
[1] Ongoing research on vaccine acceptance, immunization coverage, and barriers to COVID-19 vaccine uptake in Kazakhstan (Source: lat novels, 2025).[2] Shift in COVID-19 diagnosis patterns from asymptomatic screening to symptomatic presentations in Almaty (Source: The Lancet, 2025).[3] Broader public health issues in Kazakhstan continue to be intertwined with the COVID-19 aftermath (Source: PLOS One, 2025).[4] Mental health challenges affecting and affected by ongoing COVID-19 dynamics and healthcare system strain in Kazakhstan (Source: Journal of Global Mental Health, 2025).
- The recent study from Almaty indicates a shift from asymptomatic screenings to symptomatic presentations, which might impact the health-and-wellness of individuals by affecting case detection dynamics or healthcare-seeking behavior.
- Ongoing research on vaccine acceptance, immunization coverage, and barriers to COVID-19 vaccine uptake in Kazakhstan can provide insights into how the medical-conditions of people are being affected by the pandemic and the control efforts being taken.
